ORCID Profile
0000-0002-3848-5395
Current Organisations
University of Amsterdam
,
Nanyang Technological University
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Publisher: Informa UK Limited
Date: 06-2013
Publisher: Springer Science and Business Media LLC
Date: 17-07-2019
Publisher: American Chemical Society (ACS)
Date: 10-05-2020
Publisher: JMIR Publications Inc.
Date: 29-04-2020
DOI: 10.2196/18411
Publisher: JMIR Publications Inc.
Date: 12-09-2019
DOI: 10.2196/14914
Abstract: The efficacy of smartphone apps for improving medication adherence in type 2 diabetes is not well studied in Asian populations. This study aimed to determine the feasibility, acceptability, and clinical outcomes of using a smartphone app to improve medication adherence in a multiethnic Asian population with type 2 diabetes. We block randomized 51 nonadherent and digitally literate patients with type 2 diabetes between the ages of 21 and 75 years into two treatment arms (control: usual care intervention: usual care+Medisafe app) and followed them up for 12 weeks. Recruitment occurred at a public tertiary diabetes specialist outpatient center in Singapore. The intervention group received email reminders to complete online surveys monthly, while the control group only received an email reminder(s) at the end of the study. Barriers to medication adherence and self-appraisal of diabetes were assessed using the Adherence Starts with Knowledge-12 (ASK-12) and Appraisal of Diabetes Scale (ADS) questionnaires at baseline and poststudy in both groups. Perception toward medication adherence and app usage, attitude, and satisfaction were assessed in the intervention group during and after the follow-up period. Sociodemographic data were collected at baseline. Clinical data (ie, hemoglobin A1c, body mass index, low-density lipoprotein, high-density lipoprotein, and total cholesterol levels) were extracted from patients’ electronic medical records. A total of 51 (intervention group: 25 [49%] control group: 26 [51%]) participants were randomized, of which 41 (intervention group: 22 [88.0%] control group: 19 [73.1%]) completed the poststudy survey. The baseline-adjusted poststudy ASK-12 score was significantly lower in the intervention group than in the control group (mean difference: 4.7, P=.01). No changes were observed in the clinical outcomes. The average 12-week medication adherence rate of participants tracked by the app was between 38.3% and 100% in the intervention group. The majority ( %) of the participants agreed that the app was easy to use and made them more adherent to their medication. Our feasibility study showed that among medication-nonadherent patients with type 2 diabetes, a smartphone app intervention was acceptable, improved awareness of medication adherence, and reduced self-reported barriers to medication adherence, but did not improve clinical outcomes in a developed Asian setting.
Publisher: Elsevier BV
Date: 2014
No related grants have been discovered for Peter Sloot.